
Liquidity, historical trends, and peer comparisons.
According to Zenas BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 9.93. This represents a change of 19.91% compared to the average of 8.28 of the last 4 quarters.
The mean historical Current Ratio of Zenas BioPharma, Inc. over the last ten years is 4.26. The current 9.93 Current Ratio has changed 133.38% with respect to the historical average. Over the past ten years (40 quarters), ZBIO's Current Ratio was at its highest in in the March 2026 quarter at 11.94. The Current Ratio was at its lowest in in the December 2022 quarter at 0.
Average
4.26
Median
4.12
Minimum
2.57
Maximum
6.21
Discovering the peaks and valleys of Zenas BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.60%
Maximum Annual Current Ratio = 6.21
Minimum Annual Increase = -9.77%
Minimum Annual Current Ratio = 2.57
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 5.61 | -9.77% |
| 2024 | 6.21 | 141.60% |
| 2023 | 2.57 | -2.45% |
The current Current Ratio of Zenas BioPharma, Inc. (ZBIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.80
5-year avg
4.26
10-year avg
4.26
Zenas BioPharma, Inc.’s Current Ratio is greater than Immunovant, Inc. (7.27), less than Q32 Bio Inc. (20.30), greater than Annexon, Inc. (5.53), greater than Aclaris Therapeutics, Inc. (3.46), less than Upstream Bio, Inc. (27.99), greater than Tiziana Life Sciences Ltd (0.69), less than First Tracks Biotherapeutics Inc (14.28),
| Company | Current Ratio | Market cap |
|---|---|---|
| 7.27 | $5.99B | |
| 20.30 | $257.36M | |
| 5.53 | $645.54M | |
| 3.46 | $570.40M | |
| 27.99 | $176.64M | |
| 0.69 | $88.18M | |
| 14.28 | $1.87B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zenas BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zenas BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Zenas BioPharma, Inc.'s Current Ratio?
How is the Current Ratio calculated for Zenas BioPharma, Inc. (ZBIO)?
What is the highest Current Ratio for Zenas BioPharma, Inc. (ZBIO)?
What is the 3-year average Current Ratio for Zenas BioPharma, Inc. (ZBIO)?
What is the 5-year average Current Ratio for Zenas BioPharma, Inc. (ZBIO)?
How does the current Current Ratio for Zenas BioPharma, Inc. (ZBIO) compare to its historical average?